Answers are grounded in this paper and cite their sources.
Retrospective analysis assesses effectiveness and safety of semaglutide escalation in type 2 diabetes, suggesting potential benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: